Cerebrovascular and Neurological Disorders: Protective Role of NRF2

Cellular defense mechanisms, intracellular signaling, and physiological functions are regulated by electrophiles and reactive oxygen species (ROS). Recent works strongly considered imbalanced ROS and electrophile overabundance as the leading cause of cellular and tissue damage, whereas oxidative stress (OS) plays a crucial role for the onset and progression of major cerebrovascular and neurodegenerative pathologies. These include Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), stroke, and aging. Nuclear factor erythroid 2-related factor (NRF2) is the major modulator of the xenobiotic-activated receptor (XAR) and is accountable for activating the antioxidative response elements (ARE)-pathway modulating the detoxification and antioxidative responses of the cells. NRF2 activity, however, is also implicated in carcinogenesis protection, stem cells regulation, anti-inflammation, anti-aging, and so forth. Herein, we briefly describe the NRF2–ARE pathway and provide a review analysis of its functioning and system integration as well as its role in major CNS disorders. We also discuss NRF2-based therapeutic approaches for the treatment of neurodegenerative and cerebrovascular disorders.

[1]  Jing Chen,et al.  Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress , 2020, Oxidative medicine and cellular longevity.

[2]  Cecilia Prata,et al.  Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration , 2020, International journal of molecular sciences.

[3]  P. Boya,et al.  Age related retinal Ganglion cell susceptibility in context of autophagy deficiency , 2020, Cell Death Discovery.

[4]  Farzane Sivandzade,et al.  Traumatic Brain Injury and Blood–Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition , 2020, International journal of molecular sciences.

[5]  Farzane Sivandzade,et al.  The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study , 2019, Journal of Neuroinflammation.

[6]  Hongping Chen,et al.  NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. , 2019, Life sciences.

[7]  Farzane Sivandzade,et al.  Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood–brain barrier impairment , 2019, BMC Neuroscience.

[8]  N. Chondrogianni,et al.  Sulforaphane - role in aging and neurodegeneration , 2019, GeroScience.

[9]  J. Filosa,et al.  NLRP3 inflammasome inhibition with MCC950 improves diabetes‐mediated cognitive impairment and vasoneuronal remodeling after ischemia , 2019, Pharmacological research.

[10]  W. Liang,et al.  Expression of nuclear factor erythroid 2-related factor 2 following traumatic brain injury in the human brain , 2019, Neuroreport.

[11]  S. Doré,et al.  Critical Role of Nrf2 in Experimental Ischemic Stroke , 2019, Front. Pharmacol..

[12]  S. Shultz,et al.  Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy , 2019, Neurobiology of Disease.

[13]  Lin Zhu,et al.  Activation of the Nrf2-ARE signal pathway after blast induced traumatic brain injury in mice , 2019, The International journal of neuroscience.

[14]  Leilei Mao,et al.  Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Farzane Sivandzade,et al.  NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches , 2018, Redox biology.

[16]  A. Silva-Palacios,et al.  Nrf2: Molecular and epigenetic regulation during aging , 2018, Ageing Research Reviews.

[17]  L. Cucullo,et al.  In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity , 2018, Scientific Reports.

[18]  Farzane Sivandzade,et al.  Conventional and electronic cigarettes dysregulate the expression of iron transporters and detoxifying enzymes at the brain vascular endothelium: In vivo evidence of a gender-specific cellular response to chronic cigarette smoke exposure , 2018, Neuroscience Letters.

[19]  Farzane Sivandzade,et al.  In-vitro blood–brain barrier modeling: A review of modern and fast-advancing technologies , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  A. I. Rojo,et al.  Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A , 2018, Autophagy.

[21]  A. I. Rojo,et al.  Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy , 2018, Redox biology.

[22]  R. de Cabo,et al.  Nrf2 Deficiency Exacerbates Obesity-Induced Oxidative Stress, Neurovascular Dysfunction, Blood–Brain Barrier Disruption, Neuroinflammation, Amyloidogenic Gene Expression, and Cognitive Decline in Mice, Mimicking the Aging Phenotype , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  M. Nakazato,et al.  Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1 , 2018, FEBS open bio.

[24]  R. Donato,et al.  Nrf2-Keap1 signaling in oxidative and reductive stress. , 2018, Biochimica et biophysica acta. Molecular cell research.

[25]  J. Pi,et al.  Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling , 2018, Toxicology and applied pharmacology.

[26]  H. Solleiro-Villavicencio,et al.  Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases , 2018, Front. Cell. Neurosci..

[27]  J. Zhao,et al.  Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury , 2018, Behavioural Brain Research.

[28]  X. He,et al.  Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice , 2017, Brain, Behavior, and Immunity.

[29]  L. Cucullo,et al.  Unhealthy smokers: scopes for prophylactic intervention and clinical treatment , 2017, BMC Neuroscience.

[30]  L. Cucullo,et al.  Blood-brain barrier disruption in diabetic mice is linked to Nrf2 signaling deficits: Role of ABCB10? , 2017, Neuroscience Letters.

[31]  S. Lovestone,et al.  NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology , 2017, Redox biology.

[32]  A. I. Rojo,et al.  NRF2 controls proteostasis through the transcriptional regulation of autophagy , 2017 .

[33]  T. Abbruscato,et al.  Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure? , 2017, Redox biology.

[34]  E. Mikiciuk-Olasik,et al.  Metformin – a Future Therapy for Neurodegenerative Diseases , 2017, Pharmaceutical Research.

[35]  V. Krajka-Kuźniak,et al.  The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment , 2017, Pharmacological reports : PR.

[36]  Yanghao Hou,et al.  Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats , 2017, International immunopharmacology.

[37]  Leena Kadam,et al.  Rosiglitazone Regulates TLR4 and Rescues HO-1 and NRF2 Expression in Myometrial and Decidual Macrophages in Inflammation-Induced Preterm Birth , 2017, Reproductive Sciences.

[38]  Makoto Kobayashi,et al.  Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time , 2017, Molecules.

[39]  G. Deeb,et al.  Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury , 2017, Front. Neurol..

[40]  T. Abbruscato,et al.  Role of Nrf2 and protective effects of Metformin against tobacco smoke-induced cerebrovascular toxicity , 2017, Redox biology.

[41]  M. Mishra,et al.  Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2 , 2017, Free radical biology & medicine.

[42]  S. Salim,et al.  Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[43]  X. Zhao,et al.  Sulforaphane activates the cerebral vascular Nrf2–ARE pathway and suppresses inflammation to attenuate cerebral vasospasm in rat with subarachnoid hemorrhage , 2016, Brain Research.

[44]  P. Evans,et al.  Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways. , 2016, Vascular pharmacology.

[45]  Manisha N. Patel Targeting Oxidative Stress in Central Nervous System Disorders. , 2016, Trends in pharmacological sciences.

[46]  S. Kügler,et al.  Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. , 2016, Antioxidants & redox signaling.

[47]  N. Suwanwela,et al.  Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. , 2016, Microvascular research.

[48]  Xupeng Bai,et al.  Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters , 2016, Drug metabolism reviews.

[49]  H. Hara,et al.  Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation , 2016, Neurobiology of Disease.

[50]  T. Kensler,et al.  Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphane. , 2016, Seminars in oncology.

[51]  H. D. de Vries,et al.  Morphogens and blood-brain barrier function in health and disease , 2016, Tissue barriers.

[52]  Qin M. Chen,et al.  Nrf2 protects mitochondrial decay by oxidative stress , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Ying Huang,et al.  The complexity of the Nrf2 pathway: beyond the antioxidant response. , 2015, The Journal of nutritional biochemistry.

[54]  L. Cucullo,et al.  Protecting the BBB endothelium against cigarette smoke-induced oxidative stress using popular antioxidants: Are they really beneficial? , 2015, Brain Research.

[55]  A. Dinkova-Kostova,et al.  The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.

[56]  C. Mozzini,et al.  Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases. , 2015, Free radical biology & medicine.

[57]  K. Davies,et al.  Oxidative stress response and Nrf2 signaling in aging. , 2015, Free radical biology & medicine.

[58]  Takafumi Suzuki,et al.  Molecular basis of the Keap1-Nrf2 system. , 2015, Free radical biology & medicine.

[59]  L. Cucullo,et al.  Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products , 2015, Fluids and Barriers of the CNS.

[60]  F. Cabreiro,et al.  Repurposing metformin: an old drug with new tricks in its binding pockets , 2015, The Biochemical journal.

[61]  C. Sanderson,et al.  Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways , 2015, Biochemical Society transactions.

[62]  L. Cucullo,et al.  Impact of cigarette smoke extract and hyperglycemic conditions on blood–brain barrier endothelial cells , 2015, Fluids and Barriers of the CNS.

[63]  L. Cucullo,et al.  Effect of full flavor and denicotinized cigarettes exposure on the brain microvascular endothelium: a microarray-based gene expression study using a human immortalized BBB endothelial cell line , 2015, BMC Neuroscience.

[64]  F. Khodagholi,et al.  Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia , 2015, Metabolic Brain Disease.

[65]  R. Piperno,et al.  Traumatic Brain Injury and NADPH Oxidase: A Deep Relationship , 2015, Oxidative medicine and cellular longevity.

[66]  L. Cucullo,et al.  Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood–Brain Barrier Endothelial Dysfunction In Vitro , 2015, PloS one.

[67]  Han-dong Wang,et al.  Deletion of Nrf2 Exacerbates Oxidative Stress After Traumatic Brain Injury in Mice , 2015, Cellular and Molecular Neurobiology.

[68]  S. H. Young,et al.  Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells , 2014, PloS one.

[69]  R. Pi,et al.  Osthole, a Natural Coumarin Improves Cognitive Impairments and BBB Dysfunction After Transient Global Brain Ischemia in C57 BL/6J Mice: Involvement of Nrf2 Pathway , 2014, Neurochemical Research.

[70]  Guo-Yuan Yang,et al.  Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion , 2014, Journal of Neuroinflammation.

[71]  L. Gan,et al.  Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. , 2014, Biochimica et biophysica acta.

[72]  Jin He,et al.  Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. , 2014, Free radical biology & medicine.

[73]  Jian Cheng,et al.  Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke , 2014, Brain, Behavior, and Immunity.

[74]  H. Koh,et al.  Rosiglitazone inhibits chlorpyrifos-induced apoptosis via modulation of the oxidative stress and inflammatory response in SH-SY5Y cells. , 2014, Toxicology and applied pharmacology.

[75]  Xueqian Wang,et al.  Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood–Brain and Blood–Spinal Cord Barriers , 2014, The Journal of Neuroscience.

[76]  G. K. Rajanikant,et al.  Calcium ion--the key player in cerebral ischemia. , 2014, Current medicinal chemistry.

[77]  A. Cuadrado,et al.  Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.

[78]  Xinyu Lu,et al.  Genetic elimination of Nrf2 aggravates secondary complications except for vasospasm after experimental subarachnoid hemorrhage in mice , 2014, Brain Research.

[79]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[80]  S. Weber,et al.  NRF2-regulation in brain health and disease: Implication of cerebral inflammation , 2014, Neuropharmacology.

[81]  Luca Cucullo,et al.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview. , 2014, Journal of pharmacovigilance.

[82]  Akhileshwar Namani,et al.  Nrf2: bane or blessing in cancer? , 2014, Journal of Cancer Research and Clinical Oncology.

[83]  Dong Jin Kim,et al.  Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy. , 2014, Journal of medicinal chemistry.

[84]  L. Cui,et al.  Bicyclol upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia , 2014, Brain Research Bulletin.

[85]  W. Wang,et al.  Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure , 2014, Brain Research.

[86]  S. Niture,et al.  Regulation of Nrf2-an update. , 2014, Free radical biology & medicine.

[87]  A. Suzuki,et al.  Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers , 2013, Molecular and Cellular Biology.

[88]  Hung-Chuan Pan,et al.  Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. , 2013, The Journal of nutritional biochemistry.

[89]  Steven C. R. Williams,et al.  Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. , 2013, Free radical biology & medicine.

[90]  T. Mizushima,et al.  Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. , 2013, Molecular cell.

[91]  Steven Finkbeiner,et al.  Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. , 2013, Nature chemical biology.

[92]  P. Stenvinkel,et al.  Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. , 2013, Biochimie.

[93]  A. Higginbottom,et al.  S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis☆ , 2013, Free radical biology & medicine.

[94]  E. Mercken,et al.  Metformin improves healthspan and lifespan in mice , 2013, Nature Communications.

[95]  P. Hrelia,et al.  Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases , 2013, Oxidative medicine and cellular longevity.

[96]  Ye Xu,et al.  Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1-Nrf2-ARE signalling pathway after transient focal cerebral ischaemia , 2013, Brain injury.

[97]  Masayuki Yamamoto,et al.  Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration , 2013, Biology Open.

[98]  Junxia Xie,et al.  Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity. , 2013, The international journal of biochemistry & cell biology.

[99]  Joshua A. Smith,et al.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration , 2013, Neurochemistry International.

[100]  C. Goldring,et al.  The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. , 2013, Biochemical pharmacology.

[101]  He-Jin Lee,et al.  Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. , 2013, Antioxidants & redox signaling.

[102]  G. Johnson,et al.  Impaired Mitochondrial Dynamics and Nrf2 Signaling Contribute to Compromised Responses to Oxidative Stress in Striatal Cells Expressing Full-Length Mutant Huntingtin , 2013, PloS one.

[103]  L. Cui,et al.  Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice , 2013, Brain Research.

[104]  Dong Jin Kim,et al.  Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model , 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[105]  L. C. Pomatto,et al.  Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging , 2013, Redox biology.

[106]  A. Levonen,et al.  The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer☆ , 2013, Redox biology.

[107]  A. Kakita,et al.  Keap1 Is Localized in Neuronal and Glial Cytoplasmic Inclusions in Various Neurodegenerative Diseases , 2013, Journal of neuropathology and experimental neurology.

[108]  L. Gan,et al.  Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model , 2012, The Journal of Neuroscience.

[109]  S. Hadano,et al.  A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS. , 2012, Free radical biology & medicine.

[110]  M. Picklo,et al.  The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. , 2012, The Journal of nutritional biochemistry.

[111]  Q. Ma,et al.  Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2 , 2012, Pharmacological Reviews.

[112]  G. K. Rajanikant,et al.  Oxidative stress--assassin behind the ischemic stroke. , 2012, Folia neuropathologica.

[113]  S. Petri,et al.  Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS , 2012, Neurology research international.

[114]  R. Gold,et al.  Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters , 2012, International journal of molecular sciences.

[115]  Xue-bo Sun,et al.  Melatonin activates the Nrf2‐ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model , 2012, Journal of pineal research.

[116]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[117]  Takafumi Suzuki,et al.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. , 2012, Free radical biology & medicine.

[118]  Masaaki Komatsu,et al.  Keap1 degradation by autophagy for the maintenance of redox homeostasis , 2012, Proceedings of the National Academy of Sciences.

[119]  E. Jakubowska-Dogru,et al.  Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusion , 2012, Neurochemistry International.

[120]  I. Petrache,et al.  Pathogenesis of chronic obstructive pulmonary disease. , 2012, The Journal of clinical investigation.

[121]  A. Cuadrado,et al.  α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. , 2012, Human molecular genetics.

[122]  H. Aburatani,et al.  Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.

[123]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[124]  P. Rabinovitch,et al.  Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. , 2012, Human molecular genetics.

[125]  A. Hengstermann,et al.  Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease. , 2012, Chemical research in toxicology.

[126]  A. Dinkova-Kostova,et al.  Glucosinolates and isothiocyanates in health and disease. , 2012, Trends in molecular medicine.

[127]  Jeffrey N Keller,et al.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions. , 2012, Biochimica et biophysica acta.

[128]  T. Morgan,et al.  Nrf2-regulated phase II enzymes are induced by chronic ambient nanoparticle exposure in young mice with age-related impairments. , 2012, Free radical biology & medicine.

[129]  Chun-Yan Li,et al.  Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways , 2012, Neuroscience Letters.

[130]  P. Narasimhan,et al.  Minocycline-Preconditioned Neural Stem Cells Enhance Neuroprotection after Ischemic Stroke in Rats , 2012, The Journal of Neuroscience.

[131]  J. Li,et al.  Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. , 2012, Free radical biology & medicine.

[132]  R. S. Sohal,et al.  The redox stress hypothesis of aging. , 2012, Free radical biology & medicine.

[133]  H. Soininen,et al.  Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease , 2012, Progress in Neurobiology.

[134]  S. Niture,et al.  Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis* , 2012, The Journal of Biological Chemistry.

[135]  A. Wyttenbach,et al.  In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production* , 2011, The Journal of Biological Chemistry.

[136]  M. Modo,et al.  Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke , 2011, The Journal of physiology.

[137]  Na Chen,et al.  Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats , 2011, Neurochemical Research.

[138]  S. Liebner,et al.  Current concepts of blood-brain barrier development. , 2011, The International journal of developmental biology.

[139]  G. Sykiotis,et al.  Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson’s disease , 2011, Disease Models & Mechanisms.

[140]  Abhinav K. Jain,et al.  Src Subfamily Kinases Regulate Nuclear Export and Degradation of Transcription Factor Nrf2 to Switch Off Nrf2-mediated Antioxidant Activation of Cytoprotective Gene Expression* , 2011, The Journal of Biological Chemistry.

[141]  Wen Li,et al.  Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[142]  Gang Chen,et al.  Role of the Nrf2‐ARE pathway in early brain injury after experimental subarachnoid hemorrhage , 2011, Journal of neuroscience research.

[143]  T. Toki,et al.  Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. , 2011, Archives of biochemistry and biophysics.

[144]  C. Piantadosi,et al.  Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression* , 2011, The Journal of Biological Chemistry.

[145]  A. Dinkova-Kostova,et al.  The cytoprotective role of the Keap1–Nrf2 pathway , 2011, Archives of Toxicology.

[146]  K. Tufekci,et al.  The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.

[147]  M. Ekberg,et al.  The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. , 2011, Free radical biology & medicine.

[148]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[149]  H. Kaplan,et al.  Circulating Reactive Oxidant Causes Apoptosis of Retinal Pigment Epithelium and Cone Photoreceptors in the Mouse Central Retina , 2011, Ophthalmology and eye diseases.

[150]  T. Kensler,et al.  When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.

[151]  A. Cantin Cellular response to cigarette smoke and oxidants: adapting to survive. , 2010, Proceedings of the American Thoracic Society.

[152]  J. Liao,et al.  NF‐κB and innate immunity in ischemic stroke , 2010, Annals of the New York Academy of Sciences.

[153]  M. Sporn,et al.  Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. , 2010, Free radical biology & medicine.

[154]  T. Pufe,et al.  Sulforaphane suppresses LPS-induced inflammation in primary rat microglia , 2010, Inflammation Research.

[155]  D. Crawford,et al.  The Ubiquitin-conjugating Enzyme UbcM2 Can Regulate the Stability and Activity of the Antioxidant Transcription Factor Nrf2* , 2010, The Journal of Biological Chemistry.

[156]  A. M. Martín-Moreno,et al.  Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease , 2010, Glia.

[157]  B. Strooper Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process , 2010 .

[158]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[159]  F. Khodagholi,et al.  Stabilization of transcription factor Nrf2 by tBHQ prevents oxidative stress-induced amyloid beta formation in NT2N neurons. , 2010, Biochimie.

[160]  G. Fiskum,et al.  Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation , 2009, Journal of neuroscience research.

[161]  A. I. Rojo,et al.  The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK‐3beta: connecting neurotransmission with neuroprotection , 2009, Journal of neurochemistry.

[162]  A. Cuadrado,et al.  Role of microglial redox balance in modulation of neuroinflammation , 2009, Current opinion in neurology.

[163]  D. MacEwan,et al.  Lipopolysaccharide-Induced Expression of NAD(P)H:Quinone Oxidoreductase 1 and Heme Oxygenase-1 Protects against Excessive Inflammatory Responses in Human Monocytes , 2008, The Journal of Immunology.

[164]  S. Petri,et al.  Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis , 2008, Journal of neuropathology and experimental neurology.

[165]  M. L. de Ceballos,et al.  The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation1 , 2008, The Journal of Immunology.

[166]  C. Iadecola,et al.  Nuclear Factor-κB Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion , 2008, The Journal of Neuroscience.

[167]  L. Franco,et al.  Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[168]  Jing Zhao,et al.  Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury , 2007, The Journal of Neuroscience.

[169]  C. Glass,et al.  Expression of Nrf2 in Neurodegenerative Diseases , 2007, Journal of neuropathology and experimental neurology.

[170]  A. I. Rojo,et al.  Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2* , 2006, Journal of Biological Chemistry.

[171]  F. Hashemi,et al.  Corticotropin Releasing Factor (CRF) Activation of NF-κB-Directed Transcription in Leukocytes , 2006, Cellular and Molecular Neurobiology.

[172]  F. Bach,et al.  Heme Oxygenase-1 Modulates the Expression of Adhesion Molecules Associated with Endothelial Cell Activation1 , 2004, The Journal of Immunology.

[173]  T. Murphy,et al.  NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons* , 2003, Journal of Biological Chemistry.

[174]  E. Zandi,et al.  Lipopolysaccharide Induces Rac1-dependent Reactive Oxygen Species Formation and Coordinates Tumor Necrosis Factor-α Secretion through IKK Regulation of NF-κB* , 2001, The Journal of Biological Chemistry.

[175]  S. Bolesta,et al.  Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. , 2000, Clinical therapeutics.

[176]  D. Stephenson,et al.  Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[177]  Y. Panahi,et al.  Oxidative stress in neurodegenerative diseases: a review , 1969 .

[178]  Sangdun Choi,et al.  Cigarette smoke and related risk factors in neurological disorders: An update. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[179]  R. León,et al.  Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. , 2016, Pharmacology & therapeutics.

[180]  S. Correia,et al.  Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies. , 2013, Journal of Alzheimer's disease : JAD.

[181]  B. de Strooper Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. , 2010, Physiological reviews.